spacer.png, 0 kB
Biotinylation Reagents PDF Print E-mail
New Products

PEG (discrete polyethylene glycol ,dPEG™) crosslinkers, modification reagents and related products are now available from Timtec Inc. dPEG compounds and their derivatives are suitable for wide range of therapeutic, diagnostic, and molecular engineering applications.

Broad range of crosslinkers and related products that now contain the discrete polyethylene glycol (dPEG) based spacers are preferred substitutes to aliphatic methylene chain spacers, X-(CH2)n-Y. Alkyl spacers have serious limitations and drawbacks in comparison to dPEG products. Conventional chain spacers have been widely used for many years for the lack of batter alternative.

With dPEG crosslinking products, you now have a set of tools that not only overcomes the drawbacks of the alkyl liners and spacers but also provides many new creative options for your research work with chain spacers.

dPEG linkers are extremely water soluble and hydrophilic, while the alkyl linkers are neither.  The water solubility and hydrophilicity of dPEGs gives them a very large range of applications.

In contrast the opposite properties in the alkyl spacers have severely limited their actual and potential uses in biological systems.  There are the aliphatic linker containing crosslinkers at the sulfo-NHS esters, which are soluble in water, commercially available. However, when the linkers are attached or crosslinked, the inherent hydrophobicity of the alkyl spacers returns, and all the disadvantages become apparent. The hydrophobic characteristics of the alkyl linkers and spacers are most often manifested through increased aggregation and precipitation in the modified or crosslinked products.

dPEG-containing compounds solve the problem by significantly decreasing and in some cases eliminating aggregation and precipitation. In addition to being water soluble, the dPEG linkers are organic soluble and can be used in organic media when this is desirable.  DPEG likes the normal organics used for conventional linkers such as DMF and DMAC, but also especially likes methylene chloride. 

Click here to see dPEG products available from TimTec 

< Prev   Next >
 

Drug Discovery News

  • Nine U.S. Health Research Centers to Receive $255 Million
    Nine health research centers have received funds to develop ways to reduce the time it takes for clinical research to become treatments for patients. The funds were awarded as part of the Clinical and Translational Science Awards (CTSA) program which is led by the National Center for Research Resources (NCRR), part of the National Institutes [...]
  • BioFocus and University of Bristol enter drug discovery collaboration in chronic pain
    Saffron Walden and Bristol, UK; 16 July 2010 – BioFocus and the University of Bristol today announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain).  BioFocus will provide hit-to-lead and lead optimization services for a Wellcome Trust funded program at the University of Bristol.  Total [...]
  • NIH Prolongs Compound-Management Arrangement with Galapagos Until End of 2012
    NIH has extended its agreement with Galapagos’ service division, BioFocus, for the operation of the Molecular Libraries Small Molecule Repository (MLSMR) through December 2012. Galapagos will thus be eligible to receive up to $8.6 million over the course of the two-year extension. The NIH MLSMR collects samples for high-throughput biological screening and distributes them to [...]
  • Aquapharm and AMRI Enter into a Novel Marine Chemistry Collaboration
    Aquapharm Biodiscovery, a leading marine biotechnology company, announced today it has signed a research agreement with Albany Molecular Research  to identify novel drug-like compounds and scaffolds with anti-microbial and anti-inflammatory activity from Aquapharm’s marine natural products library derived from its extensive collection of marine micro-organisms.Under the terms of this agreement, drawing on its substantial experience [...]
  • Volatile Organic Compounds (VOCs) on the Gulf Coastline
    Resource: EPA – United States Environmental Protection Agency Volatile Organic Compounds (VOCs) on the Gulf Coastline EPA is analyzing air samples for volatile organic compounds (VOCs) – including specifically, benzene, ethylbenzene, toluene, and xylene. EPA is sampling for these pollutants because they are present in oil and because, at elevated concentrations, they may cause health [...]
  • The NIH Molecular Libraries Program: Identifying Chemical Probes for New Medicines
    Alice McCarthy In 2003, several program leaders within the National Institutes of Health (NIH) recognized that the results from the recently completed Human Genome Project were a launching pad for further study. Now that scientists knew the genome, how could they determine gene function? In particular, how could scientists find specific biological pathways and targets that [...]
  • AstraZeneca signs malaria drug research agreement
    * JV will allow screening of 500,000 compounds * Malaria kills up to 1 million people a year * Shares up 0.2 percent LONDON, June 28 (Reuters) – Anglo-Swedish drugmaker AstraZeneca said it was opening up around 500,000 of its chemical compounds to the Medicines for Malaria Venture (MMV) to help speed up development of [...]
  • Increasing The Odds Of Hit Iidentification By Screening Against Receptor Homologs
    Abstract— Increasing the odds of hit identification in screening is of significance for drug discovery. The odds for finding a hit are closely related either to the diversity of libraries or to the availability of focused libraries. There are no truly diverse libraries and it is difficult to design focused libraries without sufficient information. Hence [...]
  • Speeding up drug screening
    Box 1: Speeding up drug screening Whole-cell assays allow new drugs to be screened for efficacy without knowing the molecular targets. High-throughput screens (HTSs) are vital in the quest for new compounds, but until recently have been lacking for Chagas disease. At the Swiss Tropical and Public Health Institute, Reto Brun provides a ‘gold standard’ [...]
  • Over 5 million compounds screened
    Data from three projects released into the public domain In its search for new molecules against malaria, MMV has so far supported the screening of more than 5 million compounds for their potential activity against the malaria parasite. Three partners of the MMV-supported early discovery projects have gone a step further and released the data [...]

Latest News and Articles

info@timtec.net Harmony Business Park Building 301-A Newark, DE 19711
Toll free 800-574-7391 T: 302-292-8500  F: 302-292-8520
spacer.png, 0 kB